BIMI International Medical Inc. (BIMI)

NASDAQ: BIMI · IEX Real-Time Price · USD

1.325

-0.005 (-0.38%)

At close: Jul 2, 2024, 4:00 PM

1.350

+0.025 (1.89%)

After-hours: Jul 2, 2024, 6:39 PM EDT

BIMI Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019	2018	2017 - 2006
Market Capitalization	15	5	19	20	29	119	Upgrade
Market Cap Growth	6.19%	-74.65%	-4.40%	-32.60%	-75.70%	1636.28%	Upgrade
Enterprise Value	19	8	23	24	29	119	Upgrade
PE Ratio	-	-0.21	-0.53	-9.77	-6.52	-7.10	Upgrade
PS Ratio	2.63	0.40	0.88	1.52	-	-	Upgrade
PB Ratio	1.76	1.17	1.67	1.17	3.33	11.75	Upgrade
P/FCF Ratio	-3.18	-0.46	-3.99	-5.17	-14.02	-346.33	Upgrade
P/OCF Ratio	-3.18	-0.46	-4.20	-5.55	-14.02	-346.33	Upgrade
EV/Sales Ratio	3.22	0.66	1.07	1.90	-	-	Upgrade
EV/EBITDA Ratio	-0.71	-0.36	-0.66	-17.17	-6.55	-7.10	Upgrade
EV/EBIT Ratio	-0.70	-0.35	-0.66	-16.51	-6.55	-7.10	Upgrade
EV/FCF Ratio	-4.79	-0.77	-4.87	-6.46	-14.07	-346.33	Upgrade
Debt / Equity Ratio	0.51	1.35	0.78	0.30	0.01	-	Upgrade
Debt / EBITDA Ratio	-0.31	-0.25	-0.25	-3.54	-0.02	-	Upgrade
Debt / FCF Ratio	-2.07	-0.53	-1.87	-1.33	-0.05	-	Upgrade
Quick Ratio	0.75	0.58	0.69	1.57	0.00	0	Upgrade
Current Ratio	1.21	0.99	0.96	1.62	1.40	1.76	Upgrade
Asset Turnover	0.17	0.32	0.40	0.35	0	0	Upgrade
Interest Coverage	-	-130.32	-182.18	-17.40	-698.32	-	Upgrade
Return on Equity (ROE)	-188.90%	-217.10%	-139.40%	-15.00%	-45.30%	-76.80%	Upgrade
Return on Assets (ROA)	-41.50%	-61.30%	-65.50%	-5.40%	-17.10%	-48.00%	Upgrade
Return on Capital (ROIC)	-65.88%	-161.41%	-160.16%	-17.53%	-11.22%	-2.10%	Upgrade
Earnings Yield	-96.09%	-473.68%	-187.60%	-10.24%	-15.34%	-14.09%	Upgrade
FCF Yield	-14.08%	-216.93%	-25.09%	-19.36%	-7.13%	-0.29%	Upgrade
Buyback Yield / Dilution	-76.67%	-396.87%	-151.24%	-30.65%	-9.25%	-5.71%	Upgrade
Total Shareholder Return	-76.67%	-396.87%	-151.24%	-30.65%	-9.25%	-5.71%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).